In the News
Diagnostics Direct and Orasure Technologies, Inc. to donate free syphilis, HIV, and HCV tests to clinics and health departments
NCSD is excited to announce their partnership with Diagnostics Direct and Orasure Technologies, Inc. who have generously donated 2,000 syphilis, HIV, and HCV tests to clinics and health departments. Apply below!
Diagnostics Direct has provided a donation to the National Coalition of STD Directors of 2,000 Syphilis Health CheckTM tests, matched by Orasure Technologies, Inc. with donations of 2,000 rapid HIV tests and rapid HCV tests. The goal of this partnership is to provide syphilis, HIV, and HCV testing to the areas that need it most such has local health department STD clinics, Family Planning Clinics, and other facilities that provide sexual health services that may benefit from having access to these tests.
These donations are often in bulk, which may be between 20 and 200 of each test. You do not have to be a member to apply. All supplies are subject to availability of stock. Submission of this form does not guarantee a donation. Questions can be directed to Cait Shea, Senior Manager of Clinical Programs.
About the tests:
Syphilis Health CheckTM are the first and only CLIA waived tests that detect Treponema pallidum antibodies in human whole blood, serum or plasma and take ten minutes to process. These tests should only be performed on patients who do not have a previous history of syphilis.
The OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test is a single-use, qualitative immunoassay to detect antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) in oral fluid, fingerstick whole blood, venipuncture whole blood and plasma specimens. The OraQuick® ADVANCE Rapid HIV-1/2 Antibody Test is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV-1 and HIV-2. This test is suitable for us in multi-test algorithms designed for statistical validation of rapid HIV test results. When multiple rapid HIV tests are available, this test should be used in appropriate multi-test algorithms.
The OraQuick® HCV Rapid Antibody Test is a single-use immunoassay for the qualitative detection of antibodies to hepatitis C virus (anti-HCV) in fingerstick whole blood specimens and venipuncture who blood specimens (EDTA, sodium heparin, lithium heparin, and sodium citrate) from individuals 15 years or older. The OraQuick® HCV Rapid Antibody Test results, in conjunction with other laboratory results and clinical information, may be used to provide presumptive evidence of infection with HCV (state of infection or associated disease not determined) in persons with signs or symptoms of hepatitis and in persons at risk for hepatitis C infection.
Questions? Connect with Cait Shea, Senior Manager of Clinical Programs at cshea@ncsddc.org.
Thank you to Diagnostics Direct and Orasure Technologies, Inc. for this generous donation!
Submission of this form does not guarantee a Syphilis Health CheckTM donation.
